BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mondal S, Pramanik S, Khare VR, Fernandez CJ, Pappachan JM. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives. World J Cardiol 2024; 16(5): 240-259 [PMID: 38817648 DOI: 10.4330/wjc.v16.i5.240]
URL: https://www.wjgnet.com/1948-9358/full/v16/i5/240.htm
Number Citing Articles
1
Xinyue Zhang, Yanxia Zhang, Jiayu Wang, Zhijia Tang. Sodium-glucose cotransporter 2 inhibitors in the treatment of heart failure patients: A systematic review and meta-analysis of cost-utility studiesArchives of Gerontology and Geriatrics 2025; 133: 105809 doi: 10.1016/j.archger.2025.105809
2
Elena Y. Rykova, Vadim V. Klimontov, Elena Shmakova, Anton I. Korbut, Tatyana I. Merkulova, Julia Kzhyshkowska. Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on MacrophagesInternational Journal of Molecular Sciences 2025; 26(4): 1670 doi: 10.3390/ijms26041670
3
Murali Krishna Moka, Melvin George, Deepalaxmi Rathakrishnan, V Jagadeeshwaran, Sriram D K. Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populationsCurrent Research in Translational Medicine 2025; 73(2): 103496 doi: 10.1016/j.retram.2025.103496
4
Samar Abed Alharbi, Amal Ahmad Alsubaiei, Ali Hussain Alkhalifah, Abdulrahman Abdulaziz Alshehri, Shoog Soliman Alhaggas, Shahad Marwan Alhuthli, Yousef Hassan Alfaqih, Wed Ziyad Alnajjar, Ghaida Abdulla Alshaban, Mahmood Sameer Ahmed, Abdulkarem Sarhan Alqarni. The role of SGLT2 inhibitors in protecting cardiovascular health: beyond glycaemic controlInternational Journal Of Community Medicine And Public Health 2025;  doi: 10.18203/2394-6040.ijcmph20250050
5
Rebecca Ayoti, Zahid Khan, Gideon Mlawa, Animesh Gupta. Assessing the Effectiveness and Safety of Combination Diuretic Therapy in Heart Failure: A Systematic Review and Meta-AnalysisCureus 2024;  doi: 10.7759/cureus.72118